Z-3244-2018 Class II Terminated
FDA device recall Z-3244-2018 was initiated by Tosoh Bioscience Inc on Jul 13, 2018 and is designated Class II. Reason for recall: Analyzers were distributed with software which lacks a 510K The recall status is terminated (terminated Jul 8, 2020). Affected quantity: 8 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 3, 2018
- Initiation Date
- Jul 13, 2018
- Termination Date
- Jul 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 units
Product description
G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.
Reason for recall
Analyzers were distributed with software which lacks a 510K
Distribution pattern
US Nationwide Distribution in states of - CA, OK, VA 7 WI
Code information
Serial Numbers: 14646304, 14917201, 14886112, 14616503, 14856212, 14887601, 14886212 & 14917201
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-3244-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.